Results 281 to 290 of about 960,477 (390)

Relationship Between Body Mass Index, Eating Disorders, Internet Addiction, and Social Media Addictions Among Adolescents in Bangladesh. [PDF]

open access: yesPublic Health Chall
Siddik MAB   +9 more
europepmc   +1 more source

ADDICTION Cases Treated on a Psychiatric Service

open access: bronze, 1967
C D Koutsky, THEODORE G. LARSON
openalex   +1 more source

Drug Addiction, Dysregulation of Reward, and Allostasis

open access: yesNeuropsychopharmacology, 2001
G. Koob, M. Moal
semanticscholar   +1 more source

Targeting of PTP4A3 overexpression sensitises HGSOC cells towards chemotherapeutic drugs

open access: yesMolecular Oncology, EarlyView.
In HGSOC with normal KRAS expression, high PTP4A3 expression regulates autophagy activation. Conversely, in HGSOC with high KRAS expression, KRAS dictates autophagy control, and PTP4A3 is not required. When high PTP4A3 expression is inhibited, HGSOC cells are preferentially sensitised towards DNA‐damaging agents.
Ana López‐Garza   +3 more
wiley   +1 more source

Transcriptional Addiction in Cancer

open access: yesCell, 2017
J. Bradner, Denes Hnisz, R. Young
semanticscholar   +1 more source

Brain–gut–microbiome interactions in obesity and food addiction

open access: yesNature reviews: Gastroenterology & hepatology, 2020
Arpana Gupta, V. Osadchiy, E. Mayer
semanticscholar   +1 more source

Olaparib synergy screen reveals Exemestane induces replication stress in triple‐negative breast cancer

open access: yesMolecular Oncology, EarlyView.
Screening 166 FDA‐approved anticancer drugs identifies the aromatase inhibitor Exemestane as a synergistic partner of PARP inhibitor Olaparib in BRCA‐proficient triple‐negative breast cancer. Exemestane induces ROS‐mediated replication stress, enhancing DNA damage and apoptosis alongside Olaparib.
Nur Aininie Yusoh   +5 more
wiley   +1 more source

From fairytale to clinical practice: A response to commentaries. [PDF]

open access: yesAddiction
Gonzalez Utrilla M   +8 more
europepmc   +1 more source

RKIP overexpression reduces lung adenocarcinoma aggressiveness and sensitizes cells to EGFR‐targeted therapies

open access: yesMolecular Oncology, EarlyView.
RKIP, a metastasis suppressor protein, modulates key oncogenic pathways in lung adenocarcinoma. In silico analyses linked low RKIP expression to poor survival. Functional studies revealed RKIP overexpression reduces tumor aggressiveness and enhances sensitivity to EGFR‐targeted therapies, while its loss promotes resistance.
Ana Raquel‐Cunha   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy